WebType and screen patients prior to starting DARZALEX FASPRO ®. Interference With Determination of Complete Response Daratumumab is a human immunoglobulin G (IgG) kappa monoclonal antibody that can be detected on both the serum protein electrophoresis (SPE) and immunofixation (IFE) assays used for the clinical monitoring of endogenous M … WebNov 16, 2015 · Type and screen patients prior to starting DARZALEX. Interference with Determination of Complete Response - Daratumumab is a human IgG kappa monoclonal antibody that can be detected on both, the serum protein electrophoresis (SPE) and immunofixation (IFE) assays used for the clinical monitoring of endogenous M-protein.
HIGHLIGHTS OF PRESCRIBING INFORMATION DARZALEX …
WebDec 11, 2024 · DARZALEX ® has become a backbone therapy in the treatment of multiple myeloma, having been used in the treatment of more than 227,000 patients worldwide … WebDARZALEX FASPRO ® (daratumumab and hyaluronidase-fihj) is indicated for the treatment of adult patients with multiple myeloma: In combination with bortezomib, melphalan, and prednisone in newly diagnosed patients who are ineligible for … eugene oregon flight schedule
New Clinical and Real-World Data Support Use of DARZALEX
WebDaratumumab is the generic name for the trade name drug Darzalex. In some cases, health care professionals may use the trade name Darzalex when referring to the generic drug … WebFeb 22, 2024 · Notify blood transfusion centers of this interference with serological testing and inform blood banks that a patient has received DARZALEX ®. Type and screen patients prior to starting DARZALEX ®. Neutropenia and Thrombocytopenia. DARZALEX ® may increase neutropenia and thrombocytopenia induced by background therapy. … WebDec 7, 2024 · Type and screen patients prior to starting DARZALEX ®. Neutropenia and Thrombocytopenia. DARZALEX ® may increase neutropenia and thrombocytopenia induced by background therapy. Monitor complete ... firm abs fitness